Peng Dai (Simon)

Peng (Simon) Dai has extensive work experience in finance and analysis roles. Peng (Simon) is currently working as the Director of Finance Planning & Analysis at Insilico Medicine since May 2021. Prior to this, they held various roles at WuXi AppTec, including Director of Finance Business Partner, LTD and Associate Finance Business Partner Director, RSD. In these positions, they supported business units, tracked market information, created financial models for financing activities, and partnered with the Corporate FP&A team. Before joining WuXi AppTec, Peng worked at Thermo Fisher Scientific as a Senior Financial Planning Analyst and Financial Analyst, where they were responsible for regional-level management reports, forecasting, budgeting, and financial analysis. Peng (Simon) also has auditing experience at Deutsche Bank.

Peng (Simon) Dai attended the University of Adelaide from 2006 to 2009, where they completed a Bachelor of Commerce (BCom) degree with a specialization in Accounting. Peng (Simon) later pursued a Master of Commerce degree in Applied Finance at the same university, which they completed in 2011. Additionally, Peng (Simon) Dai had some involvement with CPA Australia, although the specific details regarding degree and field of study are not provided.